Co-Authors
This is a "connection" page, showing publications co-authored by Chih-Yi Liao and Nicholas Feinberg.
Connection Strength
0.333
-
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 11 01; 31(11).
Score: 0.217
-
Surgical liver debulking and bland embolization for controlling liver metastases in patients with neuroendocrine tumors: A comparative effectiveness analysis. Surgery. 2026 Sep 02; 110594.
Score: 0.062
-
Surgery enhances the effectiveness of peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2025 01; 177:108834.
Score: 0.054